griseofulvin microsize

Generic: griseofulvin

Labeler: chartwell rx, llc.
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name griseofulvin microsize
Generic Name griseofulvin
Labeler chartwell rx, llc.
Dosage Form TABLET
Routes
ORAL
Active Ingredients

griseofulvin 500 mg/1

Manufacturer
Chartwell RX, LLC.

Identifiers & Regulatory

Product NDC 62135-496
Product ID 62135-496_2589e87e-f74c-cbf4-e063-6394a90a402f
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA060569
Listing Expiration 2026-12-31
Marketing Start 1971-09-09

Pharmacologic Class

Established (EPC)
tubulin inhibiting agent [epc]
Physiologic Effect
decreased mitosis [pe] microtubule inhibition [pe]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 62135496
Hyphenated Format 62135-496

Supplemental Identifiers

RxCUI
310600
UPC
0362135496302
UNII
32HRV3E3D5
NUI
N0000008732 N0000175085 N0000175848

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name griseofulvin microsize (source: ndc)
Generic Name griseofulvin (source: ndc)
Application Number ANDA060569 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 500 mg/1
source: ndc
Packaging
  • 100 TABLET in 1 BOTTLE (62135-496-01)
  • 30 TABLET in 1 BOTTLE (62135-496-30)
source: ndc

Packages (2)

62135-496-01 100 TABLET in 1 BOTTLE (62135-496-01) 62135-496-30 30 TABLET in 1 BOTTLE (62135-496-30)

Ingredients (1)

griseofulvin (500 mg/1)

Linked Drug Pages (1)

Griseofulvin MICROSIZE ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "2589e87e-f74c-cbf4-e063-6394a90a402f", "openfda": {"nui": ["N0000008732", "N0000175085", "N0000175848"], "upc": ["0362135496302"], "unii": ["32HRV3E3D5"], "rxcui": ["310600"], "spl_set_id": ["6902a976-b0c5-48a4-8d50-984002be6c3a"], "pharm_class_pe": ["Decreased Mitosis [PE]", "Microtubule Inhibition [PE]"], "pharm_class_epc": ["Tubulin Inhibiting Agent [EPC]"], "manufacturer_name": ["Chartwell RX, LLC."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET in 1 BOTTLE (62135-496-01)", "package_ndc": "62135-496-01", "marketing_start_date": "20201231"}, {"sample": false, "description": "30 TABLET in 1 BOTTLE (62135-496-30)", "package_ndc": "62135-496-30", "marketing_start_date": "20201231"}], "brand_name": "Griseofulvin MICROSIZE", "product_id": "62135-496_2589e87e-f74c-cbf4-e063-6394a90a402f", "dosage_form": "TABLET", "pharm_class": ["Decreased Mitosis [PE]", "Microtubule Inhibition [PE]", "Tubulin Inhibiting Agent [EPC]"], "product_ndc": "62135-496", "generic_name": "griseofulvin", "labeler_name": "Chartwell RX, LLC.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Griseofulvin MICROSIZE", "active_ingredients": [{"name": "GRISEOFULVIN", "strength": "500 mg/1"}], "application_number": "ANDA060569", "marketing_category": "ANDA", "marketing_start_date": "19710909", "listing_expiration_date": "20261231"}